Jan H von der Thusen
Overview
Explore the profile of Jan H von der Thusen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
123
Citations
1866
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Moonen L, Derks J, Hillen L, van Suylen R, den Bakker M, von der Thusen J, et al.
Endocr Relat Cancer
. 2024 Jun;
31(9).
PMID: 38855984
The predictive value of the extent of peri-operative lymph node (LN) sampling in relation to disease relapse in patients with pulmonary carcinoid (PC) is unknown. Furthermore, post-surgery follow-up recommendations rely...
12.
Ernst S, van Marion R, von der Thusen J, Dubbink H, Dingemans A
Lung Cancer
. 2024 Jun;
193:107844.
PMID: 38833851
No abstract available.
13.
van Kooten J, Dietz M, Dubbink H, Verhoef C, Aerts J, Madsen E, et al.
Clin Exp Med
. 2024 Apr;
24(1):80.
PMID: 38642130
Peritoneal mesothelioma (PeM) is an aggressive tumor with limited treatment options. The current study aimed to evaluate the value of next generation sequencing (NGS) of PeM samples in current practice....
14.
Ernst S, van Marion R, Atmodimedjo P, de Jonge E, Mathijssen R, Paats M, et al.
J Thorac Oncol
. 2024 Apr;
19(7):995-1006.
PMID: 38615940
Introduction: For patients with KRAS-mutated NSCLC who are treated with sotorasib, there is a lack of biomarkers to guide treatment decisions. We therefore investigated the clinical utility of pretreatment and...
15.
Ernst S, Hofman M, van der Horst T, Paats M, Heijboer F, Aerts J, et al.
EBioMedicine
. 2024 Mar;
102:105074.
PMID: 38507877
Background: Sotorasib given after immunotherapy could put patients at increased risk of hepatotoxicity. Therefore, there is a need to gain insight into the potential correlation between anti-PD-(L)1 treatment, anti-PD-(L)1 concentrations,...
16.
Lopuhaa B, Voorham Q, van Kemenade F, von der Thusen J
Virchows Arch
. 2024 Feb;
484(3):429-439.
PMID: 38413389
Since the onset of the COVID-19 pandemic, autopsies have played a valuable role in understanding the pathophysiology of COVID-19. In this study, we have analyzed COVID-19-related pathology reports from autopsies,...
17.
Lopuhaa B, Guzel C, van der Lee A, van den Bosch T, van Kemenade F, Huisman M, et al.
Histopathology
. 2024 Jan;
84(6):967-982.
PMID: 38253958
Aims: COVID-19 pneumonia is characterized by an increased rate of deep venous thrombosis and pulmonary embolism. To better understand the pathophysiology behind thrombosis in COVID-19, we performed proteomics analysis on...
18.
van Horik C, Zuidweg M, Boerema-de Munck A, Buscop-van Kempen M, Brosens E, Vahrmeijer A, et al.
Eur Respir Rev
. 2023 Dec;
32(170).
PMID: 38123235
Currently there is a global lack of consensus about the best treatment for asymptomatic congenital pulmonary airway malformation (CPAM) patients. The somatic KRAS mutations commonly found in adult lung cancer...
19.
Ernst S, Uzun S, Paats M, van Marion R, Atmodimedjo P, de Jonge E, et al.
JCO Precis Oncol
. 2023 Dec;
7:e2300451.
PMID: 38096473
No abstract available.
20.
Edel G, Hol J, Slot E, von der Thusen J, van Bever Y, de Jonge R, et al.
Lab Invest
. 2023 Aug;
103(11):100233.
PMID: 37567389
Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) is a lethal congenital lung disorder that presents shortly after birth with respiratory failure and therapy-resistant pulmonary hypertension. It is associated...